Stocks and Investing
Stocks and Investing
Mon, June 3, 2024
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
Bruce Jackson Reiterated (UNCY) at Buy and Held Target at $3 on, Jun 3rd, 2024
Bruce Jackson of Benchmark, Reiterated "Unicycive Therapeutics, Inc." (UNCY) at Buy and Held Target at $3 on, Jun 3rd, 2024.
Bruce has made no other calls on UNCY in the last 4 months.
There are 3 other peers that have a rating on UNCY. Out of the 3 peers that are also analyzing UNCY, 0 agree with Bruce's Rating of Hold.
These are the ratings of the 3 analyists that currently disagree with Bruce
- Ed Arce of "HC Wainwright & Co." Reiterated at Strong Buy and Held Target at $4.5 on, Wednesday, May 29th, 2024
- Yasmeen Rahimi of "Piper Sandler" Initiated at Buy and Held Target at $9 on, Thursday, April 4th, 2024
- Robert LeBoyer of "Noble Capital Markets" Initiated at Buy and Held Target at $6 on, Wednesday, February 14th, 2024
Contributing Sources